slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 40,231-40,260
Pages 1,935
Rows per page 30
Slide function
40,231-40,260 of 58,039
16
The slide uses a table to compare patient demographics and clinical characteristics across different cancer types, specifically focusing on the sufficiency of the melanoma cohort for further development.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
19
The table highlights key clinical metrics including ORR, cORR, mDOR, and mFU for various patient subgroups.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
21
Data cut-off Sep 30, 2023. N=16 patients.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
22
Data cut-off Sep 30, 2023. Includes extensive footnotes regarding methodology and specific patient cases.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
28
Includes specific clinical details on Grade 3/4 events for two patients in the highest dose cohort (DL4b).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
29
Data cut-off Sep 30, 2023. Slide 29.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
53
The slide illustrates the methodology for PK analysis (injection, sampling, quantification) and presents the resulting concentration-time curve.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
71
Includes waterfall plot and spider plot for RECIST 1.1 response metrics.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
73
Data cut-off Sep 30, 2023. N=21 patients.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
74
Data cut-off Sep 30, 2023. N=28 patients.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
39
The table compares CRS and ICANS incidence and management across three dosage groups (150x10^6, 450x10^6, and 800x10^6 cells).Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
35
The table displays clinical safety data for NXC-201, specifically focusing on Cytokine Release Syndrome and Immune cell associated Neurotoxicity.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
36
The table displays clinical trial data for NXC-201, specifically focusing on safety profiles and management interventions.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
04
Flowchart shows patient progression from screening to dosing and categorization by infection site.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
Clinical trial results presentation.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
The slide highlights that these secondary analyses were not powered for statistical significance.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide uses a split-layout with key takeaways on the left and supporting clinical data tables on the right.Innoviva | Results Presentation Deck | 7 slides · Innoviva
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
15
Innoviz | Results Presentation Deck | 20 slidesInnoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · KPI OverviewLoop · Why Now1 hit
17
The slide includes a dual-bar chart comparing Q3 2023 revenue against Q3 2022 (YoY) and Q2 2023 (QoQ).Innoviz | Results Presentation Deck | 20 slides · Innoviz Technologies
Conference presentation Investor relations Beat · Cash PositionLoop · Why Now1 hit
09
Includes pro forma adjustments for exited businesses and geographies.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
The slide uses stacked bar charts to show revenue composition across four segments: Data/Patient Network, Women's health, Rare diseases/Other, and Oncology.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The table highlights significant restructuring charges impacting GAAP results in Q3 2023.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Non-GAAP measures. See reconciliation for GAAP to non-GAAP in Appendix. Drawings not to scale.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
The slide presents two metrics: 'Change in cash/investments' (table) and 'Ongoing cash burn' (bar chart), with detailed footnotes explaining adjustments.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The slide uses a mix of bar charts and a line-bar combo chart to track operational and financial performance metrics over four quarters.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Includes footnotes regarding pro forma adjustments and cash definitions.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
Includes footnotes regarding company realignment and exited businesses.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations 1 hit
21
Includes footnotes regarding company realignment and rounding.Invitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations 1 hit
22
Trended 8 quarter view at ir.invitae.comInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations 1 hit
23
Trended 8 quarter view at ir.invitae.comInvitae | Results Presentation Deck | 27 slides · Invitae
Conference presentation Investor relations 1 hit